Keyphrases
Two-dose
100%
Vaccination
100%
Immunogenicity
100%
Fractional Dose
100%
Polyribosylribitol Phosphate
100%
Haemophilus Influenzae Type b
100%
Dosing Regimen
100%
Economization
100%
Randomized Trial
100%
CRM197
33%
Phosphate Concentration
22%
Alternative Regimens
22%
Conjugate Vaccine
22%
Haemophilus Influenzae Type b Vaccine
22%
Chilean
11%
Developed Countries
11%
Diphtheria
11%
Polysaccharide
11%
Vaccination Schedule
11%
Capsular Polysaccharide
11%
Two-dose Schedule
11%
Tetanus Toxoid
11%
Carrier Priming
11%
Oligosaccharides
11%
Tetanus Vaccine
11%
Antibody Concentration
11%
Diphtheria-tetanus-pertussis
11%
Protective Antibodies
11%
Toxoid
11%
Pharmacology, Toxicology and Pharmaceutical Science
Immunogenicity
100%
Haemophilus Influenzae Type B
100%
Diphtheria Toxoid CRM197
60%
Conjugate Vaccine
60%
Diphtheria
40%
Polysaccharide
40%
Tetanus
20%
Diphtheria Pertussis Tetanus Vaccine
20%
Oligosaccharide
20%
Haemophilus Influenzae Type B Vaccine
20%
Tetanus Toxoid
20%
Toxoid
20%
Pertussis
20%
Immunology and Microbiology
Haemophilus Influenzae Type B
100%
Drug Dose Regimen
100%
Immunogenicity
100%
Conjugate Vaccine
60%
Diphtheria Toxoid CRM197
60%
Tetanus Vaccine
20%
Vaccination Schedule
20%
DPT Vaccine
20%
Toxoid
20%
Hib Vaccine
20%
Antibody Blood Level
20%